Residency · Residency · Preventive Medicine
Global Burden of Disease and Health Metrics
Overview
The Global Burden of Disease (GBD) study, coordinated by the Institute for Health Metrics and Evaluation (IHME), quantifies health loss from diseases, injuries, and risk factors worldwide. DALYs (disability-adjusted life years) are the primary metric combining premature mortality and disability. The epidemiologic transition describes the global shift from communicable to non-communicable disease burden. GBD data inform priority-setting, resource allocation, and policy evaluation at national and global levels. Understanding health metrics (DALYs, HALEs, YLLs, YLDs) is essential for preventive medicine physicians working in global and domestic health policy.
Key Health Metrics
Disability-Adjusted Life Years (DALYs)
1 DALY = 1 lost year of healthy life. DALY = YLL + YLD. YLL (Years of Life Lost): mortality component; calculated from number of deaths x standard life expectancy at age of death. YLD (Years Lived with Disability): morbidity component; calculated from prevalence x disability weight. Disability weights: values between 0 (full health) and 1 (death) assigned to health states (e.g., mild depression = 0.145, paraplegia = 0.573) Lower DALYs = better population health. Enables comparison across diseases, risk factors, geographies, and time periods.
Health-Adjusted Life Expectancy (HALE)
Expected number of years lived in full health (adjusts life expectancy for time spent in ill health) Global HALE: ~63 years (2019) vs. life expectancy ~73 years (representing ~10 years of unhealthy life) Disparity: high-income countries HALE ~70 years vs. low-income countries ~55 years. Useful for evaluating quality of life beyond mere survival.
Other Metrics
Quality-Adjusted Life Years (QALYs): used in cost-effectiveness analysis; 1 QALY = 1 year in perfect health; similar concept but measured differently from DALYs. Potential Years of Life Lost (PYLL): premature mortality before a defined age (typically 75) Mortality-to-incidence ratio: proxy for case fatality and healthcare quality.
The Global Burden of Disease Study
History and Evolution
Originated with the 1990 GBD study commissioned by the World Bank (Murray and Lopez) GBD 2019: covers 369 diseases and injuries, 87 risk factors, 204 countries and territories, from 1990-2019. Produces annual updates with increasingly granular subnational estimates. Largest collaborative effort in systematic health data synthesis globally. Data sources: vital registration, hospital records, surveys, disease registries, cohort studies, published literature.
Top Global Causes of DALYs (2019)
Neonatal disorders. Ischemic heart disease. Stroke. Lower respiratory infections. Diarrheal diseases. COPD. Diabetes. Low back pain. Road injuries. Depressive disorders.
Leading Risk Factors for DALYs (2019)
High systolic blood pressure. Tobacco. Dietary risks (high sodium, low whole grains, low fruits) Air pollution (ambient PM2.5 + household) High fasting plasma glucose. High BMI. Child and maternal malnutrition. Alcohol use. Kidney dysfunction. Occupational risks.
| Health Metric | Full Name | Components | Primary Use |
|---|---|---|---|
| DALY | Disability-Adjusted Life Year | YLL + YLD | Measures disease burden (health lost) |
| YLL | Years of Life Lost | Deaths × standard life expectancy at age of death | Quantifies premature mortality |
| YLD | Years Lived with Disability | Prevalence × disability weight | Quantifies morbidity burden |
| HALE | Health-Adjusted Life Expectancy | Life expectancy adjusted for time in ill health | Quality-adjusted survival |
| QALY | Quality-Adjusted Life Year | Years × health utility (0-1) | Cost-effectiveness analysis (health gained) |
| PYLL | Potential Years of Life Lost | Deaths before age 75 × years remaining | Premature mortality impact |
The Epidemiologic Transition
Stages (Omran Model, Modified)
Age of pestilence and famine: high mortality from infectious diseases, malnutrition, maternal causes; short life expectancy (~30 years) Age of receding pandemics: declining infectious disease mortality due to sanitation, nutrition, and eventually vaccination; rising life expectancy. Age of degenerative and man-made diseases: chronic diseases (CVD, cancer, diabetes) become dominant causes of death; aging populations. Age of delayed degenerative diseases: mortality from chronic diseases shifts to older ages due to medical advances and risk factor modification. Age of re-emerging infections (proposed): HIV/AIDS, antimicrobial resistance, pandemics alongside continued NCD burden.
Double Burden of Disease
Many low- and middle-income countries face simultaneous high burden of both communicable and non-communicable diseases. Example: sub-Saharan Africa battling HIV, malaria, and TB alongside rising diabetes, hypertension, and cancer. Requires health systems that can address both categories simultaneously. Nutrition transition: undernutrition and obesity coexist within the same communities (triple burden including micronutrient deficiency)
Using GBD Data for Policy
Priority-Setting
Identifying diseases and risk factors responsible for the greatest burden. Comparing burden across countries to benchmark performance. Tracking trends over time to evaluate whether interventions are working. Subnational estimates reveal within-country disparities.
Resource Allocation
Cost-per-DALY-averted is a key metric for comparing intervention cost-effectiveness. WHO-CHOICE: interventions costing <1x GDP per capita per DALY averted are considered "very cost-effective"; <3x GDP per capita is "cost-effective". Disease Control Priorities (DCP3): comprehensive analysis of essential health interventions by cost-effectiveness.
Limitations and Criticisms
Data quality varies enormously: vital registration coverage is complete in <60% of countries; many estimates rely on statistical modeling. Disability weights derived from population surveys may not reflect lived experience of disability. DALYs do not capture equity, human rights, or social dimensions of health. Age-weighting and discounting (used in early GBD) were controversial and subsequently removed. May underestimate mental health burden and overestimate conditions with better data availability.
<image>A horizontal bar chart showing the top 10 global causes of DALYs in 2019, with bars divided into YLL (years of life lost) and YLD (years lived with disability) components. Neonatal disorders, ischemic heart disease, and stroke lead the chart. The visual distinction between YLL-dominant conditions (neonatal, infections) and YLD-dominant conditions (low back pain, depression) illustrates the different patterns of health burden. GBD education illustration.</image>
<image>A world map showing the epidemiologic transition status of different regions: high-income countries (predominantly NCD burden), sub-Saharan Africa (predominantly communicable disease burden), and middle-income countries in transition (double burden). The map uses color gradients to show the ratio of communicable to non-communicable DALY burden. Key data points are annotated for selected countries. Epidemiologic transition education illustration.</image>
<image>A diagram explaining the DALY calculation: a horizontal timeline representing a life from birth to standard life expectancy. A disease event causes years lived with disability (YLD, shown in yellow) from onset to death, and years of life lost (YLL, shown in red) from premature death to expected life span. The formula DALY = YLL + YLD is shown. A worked example calculates DALYs for a hypothetical case of stroke at age 55 with death at age 65 vs. life expectancy of 80. DALY calculation education illustration.</image>
Clinical Pearls
DALYs combine mortality AND morbidity into a single metric -- conditions like depression and low back pain rank among the top global causes of DALYs despite low mortality because of their high YLD (disability) component. High systolic blood pressure is the number one risk factor for global DALYs -- this underscores why population-level hypertension prevention (sodium reduction, DASH diet) is among the most impactful public health interventions. The double burden of disease means low- and middle-income countries must build health systems capable of addressing infections and NCDs simultaneously -- vertical disease programs alone are insufficient. For boards: be able to calculate and interpret DALYs (YLL + YLD), distinguish DALYs from QALYs, name the top global risk factors, and describe the epidemiologic transition stages. GBD estimates are only as good as the underlying data -- in countries without complete vital registration, burden estimates rely heavily on statistical modeling and should be interpreted with appropriate uncertainty.
References
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries. Lancet. 2020;396(10258):1204-1222.
- GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries. Lancet. 2020;396(10258):1223-1249.
- Murray CJL, Lopez AD. The Global Burden of Disease. WHO/Harvard/World Bank; 1996.
- Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 1971;49(4):509-538.
- Jamison DT, et al. Disease Control Priorities. 3rd ed. (DCP3). World Bank; 2018.
